Exogenous surfactant in ischemia/reperfusion: Effects on endogenous surfactant pools

Journal of Heart and Lung Transplantation

Volumn 29, Issue 3, 2010, Pages 327-334

  Mühlfeld, Christian ^a,b   Becker, Laura ^a   Bussinger, Christine ^a   Vollroth, Marcel ^c,d   Nagib, Ragi ^c   Schaefer, Inga Marie ^a   Knudsen, Lars ^a   Richter, Joachim ^e   Madershahian, Navid ^f   Wahlers, Thorsten ^c,f   Wittwer, Thorsten ^c,f   Ochs, Matthias ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

alveolar epithelial type II cells; electron microscopy; ischemia reperfusion; lung transplantation; stereology; surfactant

Indexed keywords

PORACTANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COMPOSITION; CELL COUNT; CELL VOLUME; CONTROLLED STUDY; ELECTRON MICROSCOPY; ISCHEMIA; LAMELLAR BODY; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; LUNG INJURY; MALE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; STEREOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; LUNG INJURY; LUNG TRANSPLANTATION; MALE; PULMONARY ALVEOLI; PULMONARY SURFACTANTS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SURFACE-ACTIVE AGENTS;

EID: 77349117801     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.07.019     Document Type: Article

References (47)

1. Christie J.D., Carby M., Bag R., et al. Report of the ISHLT working group on primary lung graft dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 24 (2005) 1454-1459
2. Mulligan M.S. Primary graft dysfunction following lung transplantation: pathogenesis and impact on early and late outcomes. In: Lynch III J.P., and Ross D.J. (Eds). Lung and heart-lung transplantation (2006), Taylor and Francis, New York 437-464
3. Lee J.C., and Christie J.D. Primary graft dysfunction. Proc Am Thorac Soc 6 (2009) 39-46
4. Christie J.D., Kotloff R.M., Ahya V.N., et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 71 (2005) 1312-1316
5. Daud S.A., Yusen R.D., Meyers B.F., et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 175 (2007) 507-513
6. Fehrenbach H., Schepelmann D., Albes J.M., et al. Pulmonary ischemia/reperfusion injury: a quantitative study of structure and function in isolated heart-lungs of the rat. Anat Rec 255 (1999) 84-89
7. Mühlfeld C., Schaefer I.M., Becker L., et al. Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion. Eur Respir J 33 (2009) 625-633
8. Ochs M., Nenadic I., Fehrenbach A., et al. Ultrastructural alterations in intraalveolar surfactant subtypes after experimental ischemia and reperfusion. Am J Respir Crit Care Med 160 (1999) 718-724
9. Ochs M., Fehrenbach H., Nenadic I., et al. Preservation of intraalveolar surfactant in a rat lung ischaemia/reperfusion injury model. Eur Respir J 15 (2000) 526-531
10. De Perrot M., Liu M., Waddell T.K., et al. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167 (2003) 490-511
11. Lewis J.F., and Veldhuizen R. The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 65 (2003) 613-642
12. Dreyer N., Mühlfeld C., Fehrenbach A., et al. Exogenous surfactant application in a rat lung ischemia reperfusion injury model: effects on edema formation and alveolar type II cells. Respir Res 9 (2008) 5
13. Van Raemdonck D., Strüber M., Venuta F., et al. Strategies in the prevention and the treatment of ischaemia-reperfusion injury after lung transplantation. Eur Respir Mon 29 (2004) 66-88
14. Novick R.J., Possmayer F., Veldhuizen R.A., et al. Surfactant analysis and replacement therapy: a future tool of the lung transplant surgeon?. Ann Thorac Surg 52 (1991) 1194-1200
15. Novick R.J., MacDonald J., Veldhuizen R.A., et al. Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation. Am J Respir Crit Care Med 154 (1996) 98-104
16. Buchanan S.A., Mauney M.C., Parekh V.I., et al. Intratracheal surfactant administration preserves airway compliance during lung reperfusion. Ann Thorac Surg 62 (1996) 1617-1621
17. Erasmus M.E., Petersen A.H., Hofstede G., et al. Surfactant treatment before reperfusion improves the immediate function of lung transplants in rats. Am J Respir Crit Care Med 153 (1996) 665-670
18. Novick R.J., Gilpin A.A., Gehman K.E., et al. Mitigation of injury in canine lung grafts by exogenous surfactant therapy. J Thorac Cardiovasc Surg 113 (1997) 342-353
19. Hausen B., Rohde R., Hewitt C.W., et al. Exogenous surfactant treatment before and after sixteen hours of ischemia in experimental lung transplantation. J Thorac Cardiovasc Surg 113 (1997) 1050-1058
20. Hohlfeld J.M., Strüber M., Ahlf K., et al. Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs. Eur Respir J 13 (1999) 1037-1043
21. Erasmus M.E., Hofstede G.J., Petersen A.H., et al. SP-A-enriched surfactant for treatment of rat lung transplants with SP-A deficiency after storage and reperfusion. Transplantation 73 (2002) 348-352
22. Friedrich I., Börgermann J., Splittgerber F.H., et al. Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation. J Thorac Cardiovasc Surg 127 (2004) 335-343
23. Günther A., Balser M., Schmidt R., et al. Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration. J Thorac Cardiovasc Surg 127 (2004) 344-354
24. Van der Kaaij N.P., Haitsma J.J., Kluin J., et al. Surfactant pretreatment ameliorates ischemia-reperfusion injury of the lung. Eur J Cardiothorac Surg 27 (2005) 774-782
25. Strüber M., Hirt S.W., Cremer J., et al. Surfactant replacement in reperfusion injury after clinical lung transplantation. Intensive Care Med 25 (1999) 862-864
26. Strüber M., Fischer S., Niedermeyer J., et al. Effects of exogenous surfactant instillation in clinical lung transplantation: a prospective, randomized trial. J Thorac Cardiovasc Surg 133 (2007) 1620-1625
27. Kermeen F.D., McNeil K.D., Fraser J.F., et al. Resolution of severe ischemia-reperfusion injury post-lung transplantation after administration of endobronchial surfactant. J Heart Lung Transplant 26 (2007) 850-856
28. Amital A., Shitrit D., Raviv Y., et al. The use of surfactant in lung transplantation. Transplantation 86 (2008) 1554-1559
29. Ochs M., and Weibel E.R. Functional design of the human lung for gas exchange. In: Fishman A.P., Elias J.A., Fishman J.A., et al. (Eds). Fishman's pulmonary diseases and disorders. 4th ed. (2008), McGraw-Hill, New York 23-69
30. Gross N.J. Extracellular metabolism of pulmonary surfactant: the role of a new serine protease. Annu Rev Physiol 57 (1995) 135-150
31. Stammberger U., Gaspert A., Hillinger S., et al. Apoptosis induced by ischemia and reperfusion in experimental lung transplantation. Ann Thorac Surg 69 (2000) 1532-1536
32. Fischer S., Maclean A.A., Liu M., et al. Dynamic changes in apoptotic and necrotic cell death correlate with severity of ischemia-reperfusion injury in lung transplantation. Am J Respir Crit Care Med 162 (2000) 1932-1939
33. Ochs M., Fehrenbach H., and Richter J. Ultrastructure of canine type II pneumocytes during hypothermic ischemia of the lung: a study by means of conventional and energy filtering transmission electron microscopy and stereology. Anat Rec 263 (2001) 118-126
34. Fukuse T., Albes J.M., Takahashi Y., et al. Influence of red blood cells on lung function in an ex vivo rat heart-lung model. J Surg Res 59 (1995) 399-404
35. Mühlfeld C., Rothen-Rutishauser B., Vanhecke D., et al. Visualization and quantitative analysis of nanoparticles in the respiratory system by transmission electron microscopy. Part Fibre Toxicol 4 (2007) 11
36. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26 (1970) 57-60
37. Howard C.V., and Reed M.G. Unbiased stereology: three-dimensional measurement in microscopy, 2nd ed (2005), Garland Science/BIOS Scientific, Abingdon, UK
38. Ochs M. Stereological analysis of acute lung injury. Eur Respir Rev 15 (2006) 115-121
39. Ochs M., Schüttler M., Stichtenoth G., et al. Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran. Respir Res 7 (2006) 86
40. Lang J.D., McArdle P.J., O'Reilly P.J., et al. Oxidant-antioxidant balance in acute lung injury. Chest 122 suppl (2002) 314S-320S
41. Taut F.J., Rippin G., Schenk P., et al. A search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute). Chest 134 (2008) 724-732
42. Maitra G., Inchley K., Novick R.J., et al. Acute lung injury and lung transplantation influence in vitro subtype conversion of pulmonary surfactant. Am J Physiol Lung Cell Mol Physiol 282 (2002) L67-L74
43. Sadovski J., Kuchenbuch T., Ruppert C., et al. Keratinocyte growth factor prevents intra-alveolar oedema in experimental lung isografts. Eur Respir J 31 (2008) 21-28
44. Saugstad O.D., Curstedt T., Halliday H.L., et al. Surfactant replacement therapy from 1986 to 2006: a 20-year success story. Biol Neonate 89 (2006) 282-283
45. Fehrenbach H., Tews S., Fehrenbach A., et al. Improved lung preservation relates to an increase in tubular myelin-associated surfactant protein A. Respir Res 6 (2005) 60
46. Ikegami M., Scoville E.A., Grant S., et al. Surfactant protein-D and surfactant inhibit endotoxin-induced pulmonary inflammation. Chest 132 (2007) 1447-1454
47. Ochs M., Johnen G., Müller K.M., et al. Intracellular and intraalveolar localization of surfactant protein A (SP-A) in the parenchymal region of the human lung. Am J Respir Cell Mol Biol 26 (2002) 91-98